Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells

This publication has 45 references indexed in Scilit:

• In vivo gene transfer to the human biliary tract.
  1996
• Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve Survival
  Annals of Surgery, 1995
• Combination gene therapy for liver metastasis of colon carcinoma in vivo.
  Proceedings of the National Academy of Sciences, 1995
• Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.
  Proceedings of the National Academy of Sciences, 1994
• Gene therapy for cancer using tumour-specific prodrug activation.
  1994
• Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.
  1994
• Chapter 8 Use of Recombinant Adenovirus for Metabolic Engineering of Mammalian Cells
  Published by Elsevier ,1994
• A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.
  1993
• Cholangiocarcinoma
  Surgical Clinics of North America, 1990